It’s been a relatively smooth ride for Moderna’s global COVID-19 vaccine roll out. But on Wednesday, the company said it’s investigating the possible contamination of one batch sent to Japan.
The company has received “several complains of particulate matter” in vials of its vaccine, a Moderna spokesperson said over email.
The complaints came from “one product lot” which was distributed in Japan, the representative added. Kyodo News reported that Moderna’s vaccine partner in Japan, Takeda, has suspended the use of 1.63 million doses.
READ THE FULL REPORT HERE AT FIERCE PHARMA: